Current Cardiology Reports
GLP-1 Receptor Agonists and Cardiovascular and Kidney Outcomes by Body Mass Index in Type 2 Diabetes
ReviewGLP-1 receptor agonists
Papers on cardiorenal risk
51 papers16 new in 30 days
Wednesday, March 25
Frontiers in Nutrition
The creatinine-to-cystatin C ratio as a prognostic risk-stratification biomarker in chronic kidney disease
Cohort study of 16,031 peopleCystatin C
Monday, March 23
Current Cardiology Reports
Oral Glucagon-Like Peptide-1 Receptor Agonists for Preventing Cardiorenal Complications
ReviewGLP-1 receptor agonists
Friday, February 27
Journal of Clinical Medicine
Albuminuria as a Key Factor Associated with Ambulatory Arterial Stiffness: A Hierarchical Multivariable Analysis
Cross-sectional study of 290 peopleArterial stiffness
Friday, January 30
American Journal of Preventive Cardiology
Chronic kidney disease screening to reduce cardiovascular risk: a call to action
CommentaryChronic kidney disease
Sunday, January 18
Diabetology & Metabolic Syndrome
Acute renoprotective effects of dapagliflozin monotherapy on albuminuria and metabolic derangements in newly diagnosed type 2 diabetes mellitus: a quasi-experimental study
Non-randomized trial in 133 peopleDapagliflozin
Wednesday, January 14
Tuesday, January 13
Nature Reviews Nephrology
Next-generation therapeutics for diabetic kidney disease
ReviewDiabetic kidney disease
Monday, January 5
Monday, December 8
Cardiovascular Diabetology Endocrinology Reports
Effectiveness of SGLT2 inhibitors, incretin-based therapies, and finerenone on cardiorenal outcomes: a meta-analysis and network meta-analysis
Meta-analysis of randomized trialsSGLT2 inhibitors
Monday, November 3
AHA Scientific Sessions 2025 Abstract
Cardiorenal Protective Effects of Exercise in a Model of Diabetes and Nicotine
Experiments in ratsExercise
AHA Scientific Sessions 2025 Abstract
Sodium–Glucose Cotransporter 2 Inhibitors are Cost-Effective and Dominate Glucagon-Like Peptide-1 Receptor Agonists for Patients with Type 2 Diabetes and High Cardiorenal Risk in Canada
Computational studySGLT2 inhibitors
Friday, June 27
Friday, June 13
ADA Scientific Sessions 2025 Abstract
Impact of Smartphone-Enabled Home Urine Albuminuria Testing on Albuminuria Screening and Management
Non-randomized trial in 4,000 peopleInterventions
Tuesday, October 8
Cardiorenal Medicine
Effect of Frail Phenotype on Cardiorenal Risk and Healthcare Utilization in Older Patients with Chronic Kidney Disease
Cohort study of 203 peopleFrailty phenotype
Saturday, January 6
The Kaohsiung Journal of Medical Sciences
Recent advances in the treatment of type 2 diabetes mellitus using new drug therapies
ReviewType 2 diabetes
Thursday, December 28
Diabetes & Metabolic Syndrome
Management of type 2 diabetes in patients with compensated liver cirrhosis: Short of evidence, plenty of potential
ReviewCirrhosis
Monday, August 21
Wednesday, March 22
Friday, December 23
Monday, October 3
JAMA Network Open
Comparative Effectiveness of Empagliflozin vs Liraglutide or Sitagliptin in Older Adults With Diverse Patient Characteristics
Cohort study of 45,788 peopleEmpagliflozin